This study analyzed adverse drug event (ADE) signals associated with metreleptin using the FDA Adverse Event Reporting System (FAERS) to provide insights for safe clinical use. Data from 1 January 201
A phase 2, double-blind, placebo-controlled trial evaluated apremilast efficacy, safety, and pharmacodynamics in adults with moderate to severe atopic dermatitis (AD). Overall design: Patients were ra
Prior and Concomitant Medications and Systemic Antimicrobials Dataset Study Description This was a prospective, randomized, double-blind, multi-center, efficacy study comparing fluconazole prophylaxis
